Michael L. Cornfeldt

1.3k total citations
25 papers, 932 citations indexed

About

Michael L. Cornfeldt is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Michael L. Cornfeldt has authored 25 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Michael L. Cornfeldt's work include Neuroscience and Neuropharmacology Research (10 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Chemical synthesis and alkaloids (6 papers). Michael L. Cornfeldt is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Chemical synthesis and alkaloids (6 papers). Michael L. Cornfeldt collaborates with scholars based in United States, Canada and Austria. Michael L. Cornfeldt's co-authors include Roy Corbett, Robert W. Dunn, Mark R. Szewczak, Thyagarajan Subramanian, Doris J. Doudet, Roy A.E. Bakay, Stuart Fielding, Craig P. Smith, Natividad Stover and Ray L. Watts and has published in prestigious journals such as The Lancet Neurology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michael L. Cornfeldt

25 papers receiving 870 citations

Peers

Countries citing papers authored by Michael L. Cornfeldt

Since Specialization

Citations

This map shows the geographic impact of Michael L. Cornfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Cornfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Cornfeldt more than expected).

Fields of papers citing papers by Michael L. Cornfeldt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Cornfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Cornfeldt. The network helps show where Michael L. Cornfeldt may publish in the future.

Co-authorship network of co-authors of Michael L. Cornfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Cornfeldt. A scholar is included among the top collaborators of Michael L. Cornfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Cornfeldt. Michael L. Cornfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation 2016 ·Journal of Nuclear Medicine ·Shichun Peng, Yilong Ma, Joseph Flores, Michael L. Cornfeldt, (unknown), David Eidelberg, Doris J. Doudet	17
2	Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial 2011 ·The Lancet Neurology ·Robert E. Gross, R.L. Watts, Robert A. Hauser, Roy A.E. Bakay, Heinz Reichmann, Rüdiger von Kummer, William G. Ondo, (unknown), Wilhelm Eisner, (unknown), Harald Siedentop, K. Fichte, (unknown), Michael L. Cornfeldt, Katherine Beebe, Rupert Sandbrink	109
3	Human Retinal Pigment Epithelial Cell Implants Ameliorate Motor Deficits in Two Rat Models of Parkinson Disease 2007 ·Journal of Neuropathology & Experimental Neurology ·Ivan L. Cepeda, Joseph Flores, Michael L. Cornfeldt, John R. OʼKusky, Doris J. Doudet	23
4	Characterization and Survival of Long-Term Implants of Human Retinal Pigment Epithelial Cells Attached to Gelatin Microcarriers in a Model of Parkinson Disease 2007 ·Journal of Neuropathology & Experimental Neurology ·Joseph Flores, Ivan L. Cepeda, Michael L. Cornfeldt, John R. OʼKusky, Doris J. Doudet	17
5	Intrastriatal Implantation of Human Retinal Pigment Epithelial Cells Attached to Microcarriers in Advanced Parkinson Disease 2005 ·Archives of Neurology ·Natividad Stover, Roy A.E. Bakay, Thyagarajan Subramanian, (unknown), Michael L. Cornfeldt, (unknown), Richard C. Allen, Ray L. Watts	95
6	PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease 2004 ·Experimental Neurology ·Doris J. Doudet, Michael L. Cornfeldt, Christopher R. Honey, (unknown), Robert Allen	40
7	Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson’s disease 2003 ·Journal of neural transmission. Supplementum ·Ray L. Watts, (unknown), Natividad Stover, Michael L. Cornfeldt, (unknown), Richard C. Allen, Thyagarajan Subramanian, Doris J. Doudet, Christopher R. Honey, Roy A.E. Bakay	62
8	Synthesis and Structure−Activity Relationships of N-Propyl-N-(4-pyridinyl)-1H-indol-1-amine (Besipirdine) and Related Analogs as Potential Therapeutic Agents for Alzheimer's Disease 1996 ·Journal of Medicinal Chemistry ·Joseph Klein, (unknown), (unknown), George S. K. Wong, Francis P. Huger, Craig P. Smith, Wayne W. Petko, Michael L. Cornfeldt, Jeffrey C. Wilker, Robert D. Blitzer, E M Landau, Vahram Haroutunian, (unknown), (unknown)	56
9	ChemInform Abstract: Synthesis and Structure‐Activity Relationships of N‐Propyl‐N‐(4‐ pyridyl)‐1H‐indol‐1‐amine (Besipirdine) and Related Analogues as Potential Therapeutic Agents for Alzheimer′s Disease. 1996 ·ChemInform ·Joseph Klein, (unknown), (unknown), George S. K. Wong, Francis P. Huger, Craig P. Smith, Wayne W. Petko, Michael L. Cornfeldt, Jeffrey C. Wilker, Robert D. Blitzer, E M Landau, Vahram Haroutunian, Lisandra L. Martin, (unknown)	2
10	The pharmacological profile of iloperidone, a novel atypical antipsychotic agent. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Mark R. Szewczak, Roy Corbett, Douglas K. Rush, Carole A. Wilmot, Paul Conway, Joseph T. Strupczewski, Michael L. Cornfeldt	43
11	Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder 1993 ·Psychopharmacology ·(unknown), Craig P. Smith, Mark R. Szewczak, Robert W. Dunn, Michael L. Cornfeldt, Roy Corbett	101
12	Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents 1992 ·European Journal of Pharmacology ·Robert W. Dunn, (unknown), (unknown), Lisa L. Kerman, (unknown), Fernando Camacho, Carole A. Wilmot, Michael L. Cornfeldt, (unknown), Paul L. Wood, Roy Corbett	52
13	Cardiorespiratory effects of the novel opioid analgesic HP 736 in the anesthetized dog and conscious goat. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·John W. Hubbard, (unknown), (unknown), A. G. Brice, L. G. Pan, T. F. Lowry, (unknown), Moritz Förster, Michael L. Cornfeldt, (unknown)	4
14	GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures 1991 ·Psychopharmacology ·Roy Corbett, Stuart Fielding, Michael L. Cornfeldt, Robert W. Dunn	67
15	Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists. 1990 ·PubMed ·Robert W. Dunn, Roy Corbett, Lisandra L. Martin, Joseph F. Payack, (unknown), Carole A. Wilmot, Douglas K. Rush, Michael L. Cornfeldt, Sharmonay Fielding	8
16	Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat 1989 ·Psychopharmacology ·Kenneth W. Locke, (unknown), Michael L. Cornfeldt, Stuart Fielding	11
17	9-Amino-1,2,3,4-tetrahydroacridin-1-ols. Synthesis and evaluation as potential Alzheimer's disease therapeutics 1989 ·Journal of Medicinal Chemistry ·G. M. SHUTSKE, (unknown), (unknown), Michael L. Cornfeldt, Mark R. Szewczak, Francis P. Huger, Gina M. Bores, V. Haroutunian, Kenneth L. Davis	84
18	(.+-.)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity 1988 ·Journal of Medicinal Chemistry ·G. M. SHUTSKE, (unknown), Michael L. Cornfeldt, Mark R. Szewczak, (unknown), Gina M. Bores, Vahram Haroutunian, Kenneth L. Davis	48
19	The preclinical antipsychotic evaluation of HRP 913, a novel benzisoxazole derivative 1983 ·Drug Development Research ·Stuart Fielding, William J. Novick, (unknown), Wayne W. Petko, Jeffrey C. Wilker, (unknown), Joseph Klein, Michael L. Cornfeldt	5
20	Synthesis of spiro[isobenzofuran-1(3H),4'-piperidines] as potential central nervous system agents. 4. Central nervous system depressants 1978 ·Journal of Medicinal Chemistry ·Michael L. Cornfeldt, Stuart Fielding, (unknown), Jeffrey C. Wilker	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact